Back to search

Article

Mutation and cell state compatibility is required and targetable in Ph <i>+</i> acute lymphoblastic leukemia minimal residual disease

2024-06-10

Abstract excerpt

<h4>SUMMARY</h4> Efforts to cure BCR::ABL1 B cell acute lymphoblastic leukemia (Ph+ ALL) solely through inhibition of ABL1 kinase activity have thus far been insufficient despite the availability of tyrosine kinase inhibitors (TKIs) with broad activity against resistance mutants. The mechanisms that drive persistence within minimal residual disease (MRD) remain poorly understood and therefore untargeted. Utilizin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8966437b-fd71-5dc8-8b5e-e44d0cf2a0c6
DOI
10.1101/2024.06.06.597767
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mutation and cell state compatibility is required and targetable in Ph <i>+</i> acute lymphoblastic leukemia minimal residual diseaseDOI 10.1101/2024.06.06.597767
Select a neighboring publication to make it the new centre.